Wednesday, November 26, 2008

Clinical Trials Market Expected to Grow in India Despite Economic Crisis

Outsourcing-pharma discusses in this post that even though the country is going through a rough economic crisis, the Indian clinical trial market is predicted to continue its growth. This information comes from a partner at Ernst & Young, and he also states that biotechs increasingly turning to India will help drive growth from its current $200m a year to $600m a year in 2010, which is what KPMG predicted.

No comments:

Post a Comment